Phibro Completes Acquisition of Zoetis’ Medicated Feed Additive Business, Expanding Animal Health Portfolio

Phibro Animal Health Corp. has successfully acquired Zoetis Inc.’s medicated feed additive and certain water-soluble product lines, strengthening Phibro’s global animal health and nutrition portfolio. This acquisition introduces over 37 product lines used in cattle, swine, and poultry across 80 countries, backed by manufacturing facilities in the U.S., Italy, and China, and a workforce of 300 supporting operations.

Jack C. Bendheim, Phibro’s chairman, president, and CEO, highlighted the strategic alignment, emphasizing that the products will enable Phibro to meet high standards in animal care, disease prevention, and nutrition. The acquisition complements Phibro’s core competencies in vaccines, nutritional specialties, and mineral nutrition, and will likely enhance Phibro’s EBITDA margin and adjusted EPS, with more financial details expected in the Q1 earnings call on November 7.

Phibro COO Larry Miller called the deal a “win-win-win,” expanding solutions for customers, supporting safe and sustainable food production, and increasing revenue diversification. This acquisition provides a robust foundation for future investments in Phibro’s fast-growing animal health categories, driving long-term sustainability and growth.

Source: Feed Strategy. com
Photo Credit: BigStock. com